Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ICU Medical Inc Reaffirms FY 2013 EPS Guidance; Lowers High End Of Prior FY 2013 Revenue Guidance To A Range In Line With Analysts' Estimates


Monday, 22 Apr 2013 04:00pm EDT 

ICU Medical Inc announced that due to current business trends in certain market segments, the Company is lowering the upper end of its previously issued revenue guidance. For fiscal 2013, it expects to generate revenue in the range of $330-$337 million, compared to the previous guidance of $330-$340 million. The Company is reiterating its previous guidance of diluted earnings in the range of $2.70 to $2.85 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $335 million and EPS of $2.77 for fiscal 2013. 

Company Quote

83.08
 --
17 Dec 2014